USING QALYS VERSUS DALYS TO MEASURE COST-EFFECTIVENESS- DOES IT MATTER?

Author(s)

Feng X, Ollendorf DA, Kim DD, Cohen JT, Neumann P
Tufts Medical Center, Boston, MA, USA

Presentation Documents

OBJECTIVES : Quality-Adjusted Life Years (QALYs) and Disability-Adjusted Life Years (DALYs) are commonly used in cost-effectiveness analysis (CEA) to measure health benefits. While several studies have explored their conceptual differences, there is little data on how they differ empirically. We sought to quantify and explain differences between QALY- and DALY-based cost-effectiveness ratios when both were reported in the same evaluation, and whether using one versus the other would materially affect conclusions about an intervention’s cost-effectiveness.

METHODS : We identified CEAs using both QALYs and DALYs from the Tufts Medical Center CEA Registry (CEAs with primary results reported as cost-per-QALY) and Global Health CEA Registry (CEAs with primary results reported as cost-per-DALY), and a supplemental search to ensure comprehensive literature coverage. We calculated absolute and relative differences between the QALY- and DALY-based ratios, the latter defined as the absolute difference divided by the QALY-based ratio, and compared ratios to common benchmarks (e.g., 1x GDP per capita). We converted reported ratios into US dollars.

RESULTS : Among the eleven studies, seven focused on pharmaceuticals and infectious disease, nine were published within the last three years, and five were conducted in high-income settings. Four studies concluded the intervention was “cost-saving.” Among the eleven intervention-specific QALY- and DALY-based ratios reported from seven remaining studies, six DALY-based ratios exceeded QALY-based ratios. While relative differences ranged from 6% to 120% (median 39%), and absolute differences from approximately $2 to $15,000 (median $366), the differences were small relative to each ratio’s magnitude. Utility and/or disability weights explained most differences between ratios. The QALY-based and DALY-based ratios were consistent (both above or both below the benchmark) in 10 of 11 cases.

CONCLUSIONS : Our results suggest that while QALY-based and DALY-based ratios for the same intervention can differ, differences tend to be modest and are unlikely to materially affect resource allocation recommendations.

Conference/Value in Health Info

2019-05, ISPOR 2019, New Orleans, LA, USA

Value in Health, Volume 22, Issue S1 (2019 May)

Acceptance Code

CO2

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

No Specific Disease

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×